References
- Panza F, D'Introno A, Colacicco A, et al. Cognitive frailty: Predementia syndrome and vascular risk factors. Neurobiol Aging 2006; 27: 933–940
- Petersen R C, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985–1992
- Selkoe D J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999; 399(Suppl)A23–A31
- Henderson V W. Menopause and disorders of the central nervous system. Minerva Ginecol 2005; 57: 579–592
- Cholerton B, Gleason C E, Baker L D, Asthana S. Estrogen and Alzheimer's disease: the story so far. Drugs Aging 2002; 19: 405–427
- Bimonte-Nelson H A, Francis K R, Umphlet C D, Granholm A C. Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle-aged ovariectomized femali rats. Eur J Neurosci 2006; 24: 229–242
- Daniel J M, Hulst J L, Berbling J L. Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology 2006; 147: 607–614
- Hogervorst E, Yaffe K, Richards M, Huppert F. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev 2002; 3, CD003122
- Kurt M, Bekci B, Karakas S. Hormone replacement therapy and cognition in postmenopausal women. Maturitas 2006; 53: 39–48
- Low I F, Anstev K J. Hormone replacement therapy and cognitive performance in postmenopausal women – a review by cognitive domain. Neurosci 2006; 30: 66–84
- Burkman R T, Collins J A, Greene R A. Current perspectives on benefits and risks of hormone replacement therapy. Obstet Gynecol 2001; 185: 13–23
- Moskowitz D. A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks. Altern Med Rev 2006; 11: 208–223
- Dull P. Hormone replacement therapy. Prim Care 2006; 33: 953–963
- Kang H J, Ansbacher R, Hammoud M M. Use of alternative and complementary medicine in menopause. Int J Gynaecol Obstet 2002; 79: 195–207
- Notelovitz M. Postmenopausal tibolone therapy: biologic principles and applied clinical practice. Med Gen Med 2007; 9: 2
- Verheul H A, Kloosterboer H J. Metabolism of exogenous sex steroids and effect on brain functions with a focus on tibolone. J Steroid Biochem Mol Bio 2006; 102: 195–204
- Yaffe K, Krueger K, Cummings S R, et al. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry 2005; 162: 683–690
- Bernardi F, Pluchino N, Stomati M, Pieri M, Genazzani A R. CNS: sex steroids and SERMs. Ann N Y Acad Sci 2003; 997: 378–388
- Scheiber M D, Rebar R W. Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy?. Menopause 1999; 6: 233–241
- Kass-Annese B. Alternative therapies for menopause. Clin Obstet Gynecol 2000; 43: 162–183
- Daniel J M. Effects of oestrogen on cognition: what have we learned from basic research?. J Neuroendocrinol 2006; 18: 787–795
- Bei G, Xin Y, Min S, Yazhen L, Qinping L. Effect of raloxifene and ipriflavone on diaphyseal biomechanics in ovariectomized rats. Prog Obstet Gynecol 2007; 16: 46–49
- Genazzani A R, Bernardi F, Pluchino N, et al. Effect of tibolone administration on central and peripheral levels of allopregnanolone and beta-endorphin in female rats. Menopause 2006; 13: 57–64
- Arjmandi B H, Khalil D A, Hollis B W. Ipriflavone, a synthetic phytoestrogen, enhances intestinal calcium transport in vitro. Calcif Tissue Int 2000; 67: 225–229
- Garcia-Perez M A, Noguera R, del Val R, Noguera I, Hermenegildo C, Cano A. Comparative effects of estradiol, raloxifene, and genistein on the uterus of ovariectomized mice. Fertil Steril 2006; 86: 1003–1005
- D'Hooge R, De Deyn P P. Application of the Morris water maze in the study of learning and memory. Brain Res Rev 2001; 36: 60–90
- Sato T, Teramoto T, Tanaka K, Ohnishi Y, Irifune M, Nishikawa T. Effects of ovariectomy and calcium deficiency on learning and memory of eight-arm radial maze in middle-aged female rats. Behav Brain Res 2003; 142: 207–216
- Drake E B, Henderson V W, Stanczyk F Z, et al. Associations between circulating sex hormones and cognition in normal elderly women. Neurology 2000; 54: 599–603
- Dubal D B, Wise P M. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 2001; 142: 43–48
- Gibbs R B, Gabor R. Estrogen and cognition: applying pre-clinical findings to clinical perspectives. J Neurosci Res 2003; 74: 637–643
- Aguiar R B, Dickel O E, Cunha R W, Monserrat J M, Barros D M, Martinez P E. Estradiol valerate and tibolone: effects on memory. Pharmacol Biochem Behav 2006; 85: 689–696
- Rapp S R, Espeland M A, Shumaker S A, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. JAMA 2003; 289: 2663–2672
- Shumaker S A, Legault C, Kuller L, et al. Conjugated equine estrogen and incidence of probable dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory Study. JAMA 2004; 291: 2947–2958
- Pinkerton J V, Henderson V W. Estrogen and cognition, with a focus on Alzheimer's disease. Semin Reprod Med 2005; 23: 172–179
- Kienlen-Campard P, Tasiaux B, Octave J N. The processing and biological function of the human amyloid precursor protein (APP): lessons from different cellular models. Exp Gerontol 2000; 35: 843–850